Search Results 1-10 of 16997 for empagliflozin

  1. Empagliflozin (oral route) - Side effects & dosage - Mayo Clinic

    Description. Empagliflozin is used to treat type 2 diabetes. It works in the kidneys to prevent absorption of glucose (blood sugar). This helps lower the ...

  2. Empagliflozin and metformin (oral route) - Side effects & dosage - Mayo Clinic

    Empagliflozin and metformin combination is also used to lower the risk of worsening of kidney disease, end stage kidney disease, cardiovascular death, and ...

  3. Empagliflozin and linagliptin (oral route) - Side effects & dosage - Mayo Clinic

    Description. Empagliflozin and linagliptin combination is used together with proper diet and exercise to treat high blood sugar levels caused by type 2 ...

  4. Empagliflozin, linagliptin, and metformin (oral route) - Side effects & dosage - Mayo Clinic

    Description. Empagliflozin, linagliptin, and metformin combination is used with proper diet and exercise to lower high blood sugar levels caused by type 2 ...

  5. A Study of Heart and Kidney Protection with Empagliflozin - Mayo Clinic

    The primary purpose of this study is to investigate the effect of empagliflozin on kidney disease progression or cardiovascular death versus placebo on top of ...

  6. Pioglitazone Versus Empagliflozin For Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus - Mayo Clinic

    The purpose of this study is to evaluate efficacy of pioglitazone (PIO) versus empagliflozin (EMPA) to improve glycemic control in people with Chronic ...

  7. A Study To Test Whether Vicadrostat (BI 690517) In Combination With Empagliflozin Helps People With Heart Failure And A Weak Pumping Function Of The Left Side Of The Heart - Mayo Clinic

    A Study To Test Whether Vicadrostat (BI 690517) In Combination With Empagliflozin Helps People With Heart Failure And A Weak Pumping Function Of The Left Side ...

  9. Diabetes treatment: Medications for type 2 diabetes - Mayo Clinic

    Empagliflozin (Jardiance); Ertugliflozin (Steglatro). Action. Limit the kidneys' ability to take in sugar, which increases the amount of sugar that leaves the ...

  10. Placebo-controlled, Proof-of-concept Study To Evaluate The Safety And Efficacy Of Lanifibranor Alone And In Combination With SGLT2 Inhibitor EmpaGliflozin In PatiEnts With NASH And Type 2 Diabetes Mellitus - Mayo Clinic

    ... EmpaGliflozin In PatiEnts With NASH And Type 2 Diabetes Mellitus. Print ... empagliflozin compared to placebo on HbA1c after a 24-week treatment duration.